Cargando…

Positron emission tomography of the vulnerable atherosclerotic plaque in man – a contemporary review

Atherosclerosis is the primary underlying cause of cardiovascular disease (CVD). It is the leading cause of morbidity and mortality in the Western world today and is set to become the prevailing disease and major cause of death worldwide by 2020. In the 1950s surgical intervention was introduced to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pedersen, Sune F, Hag, Anne Mette F, Klausen, Thomas L, Ripa, Rasmus S, Bodholdt, Rasmus P, Kjær, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Invited Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237171/ https://www.ncbi.nlm.nih.gov/pubmed/24289282 http://dx.doi.org/10.1111/cpf.12105

Ejemplares similares

Imaging Atherosclerosis with Hybrid Positron Emission Tomography/Magnetic Resonance Imaging
por: Ripa, Rasmus Sejersten, et al.
Publicado: (2015)

Perfusion imaging using rubidium-82 ((82)Rb) PET in rats with myocardial infarction: First small animal cardiac (82)Rb-PET
por: Clemmensen, Andreas Ettrup, et al.
Publicado: (2016)

HIV infection and arterial inflammation assessed by (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET): A prospective cross-sectional study
por: Knudsen, Andreas, et al.
Publicado: (2014)

(64)Cu-DOTATATE PET/MRI for Detection of Activated Macrophages in Carotid Atherosclerotic Plaques: Studies in Patients Undergoing Endarterectomy
por: Pedersen, Sune Folke, et al.
Publicado: (2015)

(18)F-FDG PET Imaging of Murine Atherosclerosis: Association with Gene Expression of Key Molecular Markers
por: Hag, Anne Mette Fisker, et al.
Publicado: (2012)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques
por: Kang, Won Jun
Publicado: (2015)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond (18)F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon
por: Bucerius, Jan, et al.
Publicado: (2018)

Early risk stratification using Rubidium-82 positron emission tomography in STEMI patients
por: Ghotbi, Adam Ali, et al.
Publicado: (2017)

Positron Emission Tomography in the Differential Diagnosis of Parkinsonism
por: Rinne, Juha O
Publicado: (2009)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

[(64)Cu]Cu-DOTATATE PET metrics in the investigation of atherosclerotic inflammation in humans
por: Jensen, Jacob K., et al.
Publicado: (2022)

Ultrasound Tissue Characterization of Vulnerable Atherosclerotic Plaque
por: Picano, Eugenio, et al.
Publicado: (2015)

Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques
por: Lee, Soo Jin, et al.
Publicado: (2015)

Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
por: Stefanadis, Christodoulos, et al.
Publicado: (2017)

Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques
por: Mangge, Harald, et al.
Publicado: (2019)

Calcification in Atherosclerotic Plaque Vulnerability: Friend or Foe?
por: Shi, Xuan, et al.
Publicado: (2020)

Colchicine reduces atherosclerotic plaque vulnerability in rabbits
por: Roubille, François, et al.
Publicado: (2021)

Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2022)

Correlation Between Calcification Characteristics of Carotid Atherosclerotic Plaque and Plaque Vulnerability
por: Xu, Xiangli, et al.
Publicado: (2021)

Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models
por: Gargiulo, Sara, et al.
Publicado: (2016)

Atherosclerotic plaque vulnerability is increased in mouse model of lupus
por: Santiago-Raber, Marie-Laure, et al.
Publicado: (2020)

BIRC6 Is Associated with Vulnerability of Carotid Atherosclerotic Plaque
por: Alloza, Iraide, et al.
Publicado: (2020)

Aluminum fluoride-18 labeled folate enables in vivo detection of atherosclerotic plaque inflammation by positron emission tomography
por: Silvola, Johanna M. U., et al.
Publicado: (2018)

Role of (18)F-FDG positron emission tomography in carotid atherosclerotic plaque imaging: A systematic review
por: Ravikanth, Reddy
Publicado: (2020)

Pathophysiology of Atherosclerotic Plaque Development-Contemporary Experience and New Directions in Research
por: Kowara, Michal, et al.
Publicado: (2021)

Atherosclerotic plaque characteristics on quantitative coronary computed tomography angiography associated with ischemia on positron emission tomography in diabetic patients
por: Kamperidis, Vasileios, et al.
Publicado: (2022)

Silent Ischemic Heart Disease and Pericardial Fat Volume in HIV-Infected Patients: A Case-Control Myocardial Perfusion Scintigraphy Study
por: Kristoffersen, Ulrik S., et al.
Publicado: (2013)

Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability
por: Hutcheson, Joshua D., et al.
Publicado: (2014)

The role of near-infrared spectroscopy in the detection of vulnerable atherosclerotic plaques
por: Horvath, Martin, et al.
Publicado: (2016)

Lectin Pathway of Complement Activation Is Associated with Vulnerability of Atherosclerotic Plaques
por: Fumagalli, Stefano, et al.
Publicado: (2017)

Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque
por: Wang, Xueyu, et al.
Publicado: (2021)

Vulnerable atherosclerotic plaque features: findings from coronary imaging
por: Kurihara, Osamu, et al.
Publicado: (2021)

Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles
por: Zhang, Ming, et al.
Publicado: (2022)

Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

cGAS-STING Pathway Performance in the Vulnerable Atherosclerotic Plaque
por: Wan, Xueqi, et al.
Publicado: (2022)

Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability
por: Zhang, Ge, et al.
Publicado: (2023)

Cholesterol in human atherosclerotic plaque is a marker for underlying disease state and plaque vulnerability
por: Chen, Zhu, et al.
Publicado: (2010)

Carotid plaque inflammatory activity assessed by 2-[18F]FDG-PET imaging decrease after a neurological thromboembolic event
por: Urbak, Laerke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4bd3v885bldgfvhm921kqq11vp